rfhg_79428.1

Basic information about the TSS

---

TSS ID: rfhg_79428.1 Species: human Chr: chr6		Start: 26217035 End: 26217049 Strand: +
Source datasets	PRJNA597322
Protocol	STRIPE-seq
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3826889,EH38E2455889)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000303910.4:-60 GeneID: 3012 HGNC/MGI_ID: HGNC:4724 UniProt_ID: Q08AJ9 Nearer transcript ids and distances: EU446964:-65 BC093836:-86 BC093862:-86 NM_021052.4:-114 AK311824:-114 view more...

Gene_name: H2A clustered histone 8 Gene_symbol: H2AC8 Gene_synonyms: H2A.1 H2A/a Gene_source: HGNC:4724

TATA-Box annotation

---

Distance to TSS:	122
Nearest PromoterID:	NM_021052
Entrez ID:	3012
Nearest Unigene:	Hs.121017
Nearest Refseq:	NM_021052
Nearest Ensembl:	ENSG00000277075
Gene Name:	H2A clustered histone 8
Gene Alias:	H2A.1|H2A.2|H2A/a|H2AFA
Gene Type:	protein-coding
CpG%:	0.071429
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@H2AC8 p2@H2AC8
Sample		p1@H2AC8	p2@H2AC8
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	408.89	47.53
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	457.85	53.41
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	450.05	64.43
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	384.22	46.16
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	403.81	45.89
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	464.37	43.80
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	733.61	71.03
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	530.70	65.88
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	530.66	66.04
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	1120.42	140.85
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	1039.69	128.95
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	961.09	101.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	91.07	12.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	110.21	15.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	121.41	12.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	113.93	11.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	111.39	10.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	121.06	13.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	121.03	16.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	117.80	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	109.86	11.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	112.38	11.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	96.30	8.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	109.44	11.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	108.61	11.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	125.66	12.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	117.03	12.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	92.42	9.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	88.03	8.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	92.47	9.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	85.20	8.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	87.34	11.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	82.30	7.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	103.09	13.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	87.14	12.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	77.03	8.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	100.15	7.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	75.56	12.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	98.59	15.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	85.22	10.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	67.99	12.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	92.96	16.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	74.66	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	80.60	8.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	89.14	9.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	88.17	12.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	55.90	8.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	81.37	10.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	68.70	10.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	66.52	9.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	75.42	11.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	80.50	9.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	75.58	13.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	85.17	7.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	27.68	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	77.61	9.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	106.63	11.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	98.60	12.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	98.70	21.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	82.49	13.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	93.65	11.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	49.36	12.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	58.78	10.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	69.86	13.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	44.02	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	71.08	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	60.94	6.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	68.93	9.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	47.38	7.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	104.99	20.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	110.74	17.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	98.45	14.68
Adipocyte - breast, donor1	11376-118A8	2.53	0.32
Adipocyte - breast, donor2	11327-117E4	15.88	2.73
Adipocyte - omental, donor1	11473-119C6	4.20	0.38
Adipocyte - omental, donor2	11474-119C7	8.22	0.75
Adipocyte - omental, donor3	11475-119C8	3.01	1.34
Adipocyte - perirenal, donor1	11476-119C9	3.19	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	50.58	12.09
Adipocyte - subcutaneous, donor2	11336-117F4	11.74	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	8.34	1.74
Adipocyte differentiation, day04, donor1	13019-139D4	9.78	1.76
Adipocyte differentiation, day04, donor2	13022-139D7	4.63	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	2.79	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	5.88	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	3.30	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	2.26	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	2.13	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	3.34	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	3.33	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	3.52	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	3.65	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	187.63	27.85
Alveolar Epithelial Cells, donor2	11590-120G6	357.86	133.03
Alveolar Epithelial Cells, donor3	11671-122G6	123.40	13.18
Amniotic Epithelial Cells, donor1	11533-120A3	114.06	22.13
Amniotic Epithelial Cells, donor2	11613-122A2	120.49	15.06
Amniotic Epithelial Cells, donor3	11694-123A2	97.18	12.74
Anulus Pulposus Cell, donor1	11248-116E6	47.03	4.58
Anulus Pulposus Cell, donor2	11463-119B5	35.27	11.02
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	36.84	10.33
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	33.86	7.38
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	89.89	8.56
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	37.07	6.88
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	50.59	12.65
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	77.89	9.24
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	32.49	11.05
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	42.23	10.19
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	67.11	7.72
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	51.60	9.04
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	37.74	7.98
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	94.03	12.54
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	43.16	5.27
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	35.48	10.92
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	93.49	6.63
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	45.01	11.25
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	55.92	14.74
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	64.42	7.75
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	39.02	7.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	47.27	10.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	93.66	14.41
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	35.40	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	37.39	10.63
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	83.90	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	43.20	12.62
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	51.61	12.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	62.99	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	45.60	12.54
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	43.18	8.55
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	56.01	5.68
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	40.35	9.38
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	48.88	10.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	69.92	9.99
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	42.70	7.02
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	48.47	9.63
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	81.97	10.69
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	52.38	9.15
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	59.09	14.01
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	67.35	7.62
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	43.15	9.49
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	48.48	9.95
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	66.99	6.67
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.01	9.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	46.45	12.04
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	94.97	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	38.17	13.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	72.20	10.83
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	43.74	5.83
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	50.34	9.66
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	48.46	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	56.95	3.05
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	34.06	7.43
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	51.71	6.12
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	39.68	6.69
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	44.35	10.20
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	57.98	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	38.22	8.86
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	39.72	8.21
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	50.52	5.45
Astrocyte - cerebellum, donor1	11500-119F6	290.71	78.11
Astrocyte - cerebellum, donor2	11580-120F5	275.23	94.82
Astrocyte - cerebellum, donor3	11661-122F5	170.11	22.44
Astrocyte - cerebral cortex, donor1	11235-116D2	405.40	48.45
Astrocyte - cerebral cortex, donor2	11316-117D2	557.63	81.05
Astrocyte - cerebral cortex, donor3	11392-118C6	611.56	71.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	743.96	76.27
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	840.01	86.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	891.60	90.81
Basophils, donor1	12241-129G9	87.09	10.98
Basophils, donor2	12242-129H1	147.20	18.04
Basophils, donor3	12243-129H2	55.42	6.61
Bronchial Epithelial Cell, donor1	11511-119G8	25.66	6.04
Bronchial Epithelial Cell, donor2	11591-120G7	165.04	64.01
Bronchial Epithelial Cell, donor3	11672-122G7	100.43	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	761.97	160.05
Bronchial Epithelial Cell, donor5	11457-119A8	503.66	121.24
Bronchial Epithelial Cell, donor6	11461-119B3	365.47	70.01
Bronchial Epithelial Cell, donor7	11769-123I5	39.23	3.06
Burkitt's lymphoma cell line:DAUDI	10422-106C8	687.28	56.68
Burkitt's lymphoma cell line:RAJI	10476-106I8	316.28	34.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	1494.63	165.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	651.54	62.05
CD14+ Monocytes, donor1	11224-116B9	41.70	5.64
CD14+ Monocytes, donor2	11305-117B9	54.75	10.95
CD14+ Monocytes, donor3	11381-118B4	82.77	11.85
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	49.82	7.64
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	43.97	4.93
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	44.71	3.62
CD14+ monocytes - mock treated, donor1	11863-125A9	16.77	2.02
CD14+ monocytes - mock treated, donor2	11873-125C1	12.07	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	5.45	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9.71	2.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.00	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	8.18	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.44	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.04	1.96
CD14+ monocytes - treated with BCG, donor3	11880-125C8	12.84	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	10.07	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.92	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.52	1.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.19	1.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.37	1.67
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.63	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.82	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	7.26	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	13.96	2.09
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	7.57	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.06	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	8.45	2.11
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	7.02	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.24	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	2.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	10.13	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.88	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.97	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.58	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	59.50	10.24
CD14+CD16+ Monocytes, donor2	11801-124D1	49.89	10.16
CD14+CD16+ Monocytes, donor3	11912-125G4	51.34	7.58
CD14+CD16- Monocytes, donor1	11788-124B6	51.70	9.19
CD14+CD16- Monocytes, donor2	11799-124C8	31.09	5.94
CD14+CD16- Monocytes, donor3	11910-125G2	26.31	4.91
CD14-CD16+ Monocytes, donor1	11790-124B8	214.09	27.30
CD14-CD16+ Monocytes, donor2	11800-124C9	94.85	19.76
CD14-CD16+ Monocytes, donor3	11911-125G3	87.80	12.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	353.62	32.52
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	291.53	24.41
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	299.29	23.82
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	279.84	26.65
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	258.38	23.59
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	286.39	28.78
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	317.66	30.59
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	438.99	32.96
CD19+ B Cells, donor1	11544-120B5	171.78	53.42
CD19+ B Cells, donor2	11624-122B4	173.38	38.45
CD19+ B Cells, donor3	11705-123B4	205.46	48.46
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	2640.92	320.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	3159.17	385.11
CD34+ Progenitors, donor1	11545-120B6	1387.59	161.65
CD34+ Progenitors, donor2	11625-122B5	738.78	125.28
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	905.19	86.80
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1282.32	148.37
CD4+ T Cells, donor1	11225-116C1	280.29	37.85
CD4+ T Cells, donor2	11306-117C1	576.85	122.47
CD4+ T Cells, donor3	11382-118B5	381.55	50.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	172.28	26.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	219.66	19.09
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	248.08	14.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	633.86	99.56
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	731.12	103.24
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	362.58	75.81
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	327.62	49.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	587.02	66.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	510.05	51.26
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	344.29	61.87
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	289.99	57.65
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	155.31	18.48
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	359.24	82.22
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	909.20	98.28
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	912.84	109.93
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	326.87	49.76
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	304.96	61.10
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	247.47	52.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	623.60	96.98
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	763.79	88.81
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	735.32	79.86
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	563.24	97.58
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	447.55	54.59
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	196.12	28.33
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	296.92	30.19
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	237.26	26.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	389.43	53.04
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	139.57	26.59
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	118.03	20.86
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	195.58	24.64
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	216.66	23.28
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	307.47	26.31
CD8+ T Cells, donor1	11226-116C2	262.90	38.63
CD8+ T Cells, donor2	11307-117C2	454.65	99.86
CD8+ T Cells, donor3	11383-118B6	445.39	49.24
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	148.19	16.06
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	154.33	14.86
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	230.64	17.78
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	162.71	22.82
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	121.19	16.08
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	120.74	14.33
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	232.06	26.51
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	243.73	31.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	257.26	25.80
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	318.78	28.38
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	346.28	36.02
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	178.51	22.65
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	75.29	12.26
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	88.81	21.41
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	98.46	17.90
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	113.81	18.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	115.66	12.95
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	125.86	13.91
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	137.22	20.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	133.48	16.30
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	118.62	14.11
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	260.46	50.10
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	264.84	37.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	326.01	47.65
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	412.72	60.22
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	519.68	61.55
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	325.57	61.11
Cardiac Myocyte, donor1	11525-119I4	7.31	5.48
Cardiac Myocyte, donor2	11605-120I3	106.72	22.73
Cardiac Myocyte, donor3	11686-122I3	76.93	7.79
Chondrocyte - de diff, donor1	11261-116G1	83.55	19.76
Chondrocyte - de diff, donor2	11338-117F6	9.95	0.71
Chondrocyte - de diff, donor3	11410-118E6	18.55	1.71
Chondrocyte - re diff, donor2	11339-117F7	41.18	5.37
Chondrocyte - re diff, donor3	11411-118E7	19.01	2.83
Ciliary Epithelial Cells, donor1	11242-116D9	252.70	26.62
Ciliary Epithelial Cells, donor2	11323-117D9	144.29	27.58
Ciliary Epithelial Cells, donor3	11399-118D4	111.68	13.63
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	73.73	12.47
Corneal Epithelial Cells, donor1	11526-119I5	76.85	14.93
Corneal Epithelial Cells, donor2	11606-120I4	96.70	19.34
Corneal Epithelial Cells, donor3	11687-122I4	217.29	31.44
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	23.28	3.30
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.97	2.21
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	22.89	3.13
Dendritic Cells - plasmacytoid, donor1	11228-116C4	204.64	25.96
Dendritic Cells - plasmacytoid, donor2	11309-117C4	263.11	22.85
Dendritic Cells - plasmacytoid, donor3	11385-118B8	289.40	42.10
Endothelial Cells - Aortic, donor0	11207-116A1	351.55	34.69
Endothelial Cells - Aortic, donor1	11263-116G3	192.46	32.27
Endothelial Cells - Aortic, donor2	11340-117F8	122.17	15.27
Endothelial Cells - Aortic, donor3	11412-118E8	108.91	12.98
Endothelial Cells - Artery, donor1	11264-116G4	134.97	13.09
Endothelial Cells - Artery, donor2	11341-117F9	355.74	41.88
Endothelial Cells - Artery, donor3	11413-118E9	456.15	39.44
Endothelial Cells - Lymphatic, donor1	11236-116D3	63.84	6.87
Endothelial Cells - Lymphatic, donor2	11317-117D3	49.60	3.04
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.88	5.64
Endothelial Cells - Microvascular, donor1	11265-116G5	109.05	25.26
Endothelial Cells - Microvascular, donor2	11342-117G1	262.94	40.09
Endothelial Cells - Microvascular, donor3	11414-118F1	97.97	12.48
Endothelial Cells - Thoracic, donor1	11266-116G6	229.67	48.41
Endothelial Cells - Thoracic, donor2	11343-117G2	93.82	13.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	315.83	35.29
Endothelial Cells - Umbilical vein, donor2	11324-117E1	206.40	30.42
Endothelial Cells - Umbilical vein, donor3	11400-118D5	219.34	22.11
Endothelial Cells - Vein, donor1	11267-116G7	1336.57	207.03
Endothelial Cells - Vein, donor2	11344-117G3	723.65	115.25
Endothelial Cells - Vein, donor3	11416-118F3	268.17	27.16
Eosinophils, donor1	12244-129H3	274.44	45.74
Eosinophils, donor2	12245-129H4	23.10	1.65
Eosinophils, donor3	12246-129H5	32.10	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	41.54	8.80
Esophageal Epithelial Cells, donor2	11587-120G3	39.52	24.96
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	18.88	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	19.93	1.86
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	211.69	28.49
Fibroblast - Aortic Adventitial, donor1	11245-116E3	155.84	16.74
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	6.96	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.66	2.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	55.07	17.13
Fibroblast - Aortic Adventitial, donor3	11401-118D6	156.13	29.23
Fibroblast - Cardiac, donor1	11268-116G8	138.36	15.88
Fibroblast - Cardiac, donor2	11345-117G4	253.91	37.90
Fibroblast - Cardiac, donor3	11417-118F4	105.04	10.57
Fibroblast - Cardiac, donor4	11452-119A3	47.28	4.85
Fibroblast - Cardiac, donor5	11456-119A7	133.76	21.07
Fibroblast - Cardiac, donor6	11460-119B2	183.13	34.72
Fibroblast - Choroid Plexus, donor1	11492-119E7	35.91	11.79
Fibroblast - Choroid Plexus, donor2	11572-120E6	28.47	4.31
Fibroblast - Choroid Plexus, donor3	11653-122E6	241.69	54.20
Fibroblast - Conjunctival, donor1	11531-120A1	425.07	62.04
Fibroblast - Conjunctival, donor3	11692-122I9	40.87	3.05
Fibroblast - Dermal, donor1	11269-116G9	43.67	6.34
Fibroblast - Dermal, donor2	11346-117G5	224.52	32.07
Fibroblast - Dermal, donor3	11418-118F5	49.32	4.47
Fibroblast - Dermal, donor4	11450-119A1	727.22	149.45
Fibroblast - Dermal, donor5	11454-119A5	552.32	103.45
Fibroblast - Dermal, donor6	11458-119A9	471.03	103.95
Fibroblast - Gingival, donor1	11237-116D4	44.56	3.96
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	90.39	8.38
Fibroblast - Gingival, donor2	11318-117D4	493.40	68.40
Fibroblast - Gingival, donor3	11394-118C8	33.84	3.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	5.19
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	41.41	4.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	230.73	19.18
Fibroblast - Gingival, donor6 (control)	11922-125H5	207.30	23.12
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	175.73	18.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	164.23	19.16
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	141.53	13.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	208.42	20.07
Fibroblast - Gingival, donor9 (control)	11927-125I1	36.24	3.23
Fibroblast - Lung, donor1	11270-116H1	766.67	114.19
Fibroblast - Lung, donor2	11347-117G6	161.15	26.86
Fibroblast - Lung, donor3	11419-118F6	634.16	70.49
Fibroblast - Lymphatic, donor1	11506-119G3	37.49	14.16
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	55.98	7.84
Fibroblast - Mammary, donor1	11540-120B1	36.94	5.68
Fibroblast - Mammary, donor2	11620-122A9	223.68	47.93
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	522.37	59.74
Fibroblast - Periodontal Ligament, donor2	11319-117D5	489.93	69.93
Fibroblast - Periodontal Ligament, donor3	11395-118C9	60.28	7.04
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	107.62	17.55
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	76.68	9.99
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	39.20	4.41
Fibroblast - Pulmonary Artery, donor1	11250-116E8	287.72	25.20
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	114.40	14.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	310.71	52.79
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	108.72	21.74
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	79.97	23.02
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.63	1.78
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	26.61	3.94
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	117.63	33.70
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	81.29	14.14
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	22.78	5.06
Fibroblast - skin normal, donor1	11553-120C5	17.72	2.79
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	104.26	9.62
Fibroblast - skin normal, donor2	11561-120D4	101.27	21.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	70.12	23.27
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	36.78	2.90
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	34.02	9.57
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	46.31	11.17
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	116.43	23.54
Fibroblast - skin walker warburg, donor1	11554-120C6	121.62	19.23
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	52.53	8.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	398.88	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	95.00	22.66
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	67.09	6.24
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	56.73	7.29
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	57.49	5.11
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	1708.71	170.72
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1926.98	220.13
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1074.02	123.80
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1251.39	124.92
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	915.13	87.45
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	733.28	91.14
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1273.30	201.42
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	986.92	113.50
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	696.94	123.38
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	457.04	45.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	381.13	38.30
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	474.39	69.04
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	225.61	23.79
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	302.74	29.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	325.69	49.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	252.37	51.11
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	219.61	19.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	165.03	30.60
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	493.75	70.62
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	456.69	46.10
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	255.82	35.30
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	518.00	79.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	555.58	47.84
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	300.78	38.93
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	350.46	45.26
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	283.49	51.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	352.21	35.19
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	367.23	44.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	289.53	48.39
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	437.78	63.75
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	307.72	27.79
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	369.22	50.03
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	326.24	42.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	279.93	28.04
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	398.91	64.68
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	288.32	41.37
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	263.23	26.06
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	262.41	40.97
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	320.81	48.65
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	308.18	29.48
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	221.09	32.06
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	276.62	36.75
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	156.47	12.78
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	202.16	34.76
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	200.44	24.48
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	259.33	23.71
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	127.68	17.89
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	164.81	21.57
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	187.73	25.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	50.58	6.94
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	195.36	27.31
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	184.00	25.62
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	53.88	6.61
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	428.18	106.50
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	399.37	42.22
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	502.86	37.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	2279.38	217.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2353.69	208.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	850.00	206.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	1252.25	217.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1446.28	230.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	2103.46	186.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1121.54	149.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1882.25	272.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1358.12	168.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	886.38	143.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1648.80	239.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1201.48	179.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	961.31	145.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1327.63	189.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1468.70	207.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	1998.36	279.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1633.91	251.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1352.35	206.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1370.56	188.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	1394.64	198.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	1301.84	264.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	1538.40	316.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1490.37	323.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1449.92	220.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1611.90	221.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	1357.30	301.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	666.54	107.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	703.20	126.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	1417.91	247.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1112.84	178.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	993.95	153.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1722.98	298.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	1337.49	237.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	1540.48	341.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	1668.07	396.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	653.50	147.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	786.66	161.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1104.29	175.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	1266.50	263.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	199.73	19.40
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	53.64	11.23
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1169.43	106.82
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.15	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.03	2.92
Hep-2 cells mock treated, biol_rep1	11898-125E8	175.69	18.68
Hep-2 cells mock treated, biol_rep2	11899-125E9	146.35	21.27
Hep-2 cells mock treated, biol_rep3	11900-125F1	139.91	20.48
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	171.29	25.47
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	122.93	18.70
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	115.61	22.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	97.51	10.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	73.77	12.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	71.12	11.53
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	121.44	34.70
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	215.10	33.33
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	346.34	23.79
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	49.73	11.64
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	75.56	10.17
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	486.58	76.05
Hepatocyte, donor1	11523-119I2	9.68	6.05
Hepatocyte, donor2	11603-120I1	9.70	4.31
Hepatocyte, donor3	11684-122I1	26.38	7.36
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	2221.09	438.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	156.95	20.97
Iris Pigment Epithelial Cells, donor1	11530-119I9	81.64	10.43
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3846.14	585.84
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	3257.55	520.67
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	6770.82	81.25
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2831.05	437.46
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	1729.34	257.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	4593.02	106.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	4062.21	738.12
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	2669.33	479.93
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	4319.09	740.69
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	2159.16	425.16
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	1615.60	297.71
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	4614.94	747.76
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2128.60	402.44
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	2283.89	382.39
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3394.96	270.21
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	2538.01	399.03
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	2136.67	409.77
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	4000.26	344.98
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3564.38	645.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	2413.54	442.08
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4467.16	388.70
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2838.34	355.58
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	1595.34	445.55
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4165.50	367.28
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	1763.47	349.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	2156.55	392.10
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2001.44	175.60
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2281.06	382.75
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	1960.75	427.53
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	4300.17	386.33
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3373.08	560.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	2513.85	460.05
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3218.37	302.26
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3638.03	577.78
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	2260.02	458.33
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	4092.30	327.04
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	4546.09	633.80
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	3335.77	729.70
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	2014.93	174.08
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3143.28	563.68
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3139.98	537.47
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	3415.75	293.45
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4072.09	721.47
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3449.50	651.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4670.06	453.40
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6285.90	1055.15
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	5390.64	822.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6712.14	568.59
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	3970.68	641.46
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	4023.64	675.36
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	5240.90	477.70
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	5645.25	1077.01
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	4594.42	738.83
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5211.78	456.78
Keratinocyte - epidermal, donor1	11272-116H3	43.90	5.96
Keratinocyte - epidermal, donor2	11349-117G8	364.85	64.42
Keratinocyte - epidermal, donor3	11421-118F8	227.74	24.04
Keratinocyte - oral, donor1	11251-116E9	115.79	11.92
Keratocytes, donor1	11527-119I6	174.67	24.07
Keratocytes, donor2	11607-120I5	128.90	29.30
Keratocytes, donor3	11688-122I5	24.11	2.96
Krukenberg tumor cell line:HSKTC	10687-109F3	63.74	17.58
Lens Epithelial Cells, donor1	11529-119I8	148.87	35.60
Lens Epithelial Cells, donor2	11609-120I7	117.64	14.19
Lens Epithelial Cells, donor3	11690-122I7	42.28	3.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	158.54	16.13
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	194.79	27.63
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	118.85	14.17
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	141.42	13.44
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	235.11	28.05
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	160.21	17.47
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	105.06	15.59
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	253.33	33.37
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	131.04	16.75
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	142.79	15.82
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	188.84	29.47
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	211.07	23.88
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	152.26	20.21
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	205.37	26.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	182.26	21.70
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	146.90	15.71
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	264.98	37.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	173.84	18.12
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	146.45	18.43
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	211.75	32.51
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	196.90	20.41
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	149.85	22.79
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	255.56	26.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	177.72	18.01
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	132.71	16.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	209.60	28.69
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	191.87	22.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	136.20	16.51
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	237.44	24.27
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	236.34	24.17
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	110.48	13.08
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	214.35	23.49
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	178.16	23.17
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	99.96	13.33
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	212.49	24.21
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	177.78	24.75
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	115.79	17.37
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	209.38	21.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	173.28	23.79
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	147.91	16.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	215.73	36.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	210.07	25.52
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	150.05	18.26
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	220.18	23.52
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	233.54	27.31
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	111.38	12.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	267.91	25.61
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	162.90	18.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	759.11	83.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	625.21	107.40
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	460.18	63.09
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	831.45	121.44
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	634.40	99.87
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	528.62	95.26
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	540.52	84.50
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	628.03	98.73
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	627.23	69.22
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	273.38	48.57
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	285.86	44.57
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	561.45	64.63
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	574.12	91.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	236.06	37.40
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	223.88	27.98
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	695.31	120.72
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	283.61	41.89
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	413.03	59.52
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	865.12	120.87
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	687.40	117.42
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	357.97	53.31
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	322.30	49.61
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	636.75	89.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	422.97	62.42
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	310.29	52.01
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	281.05	38.73
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	745.50	121.25
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	641.68	90.72
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	689.61	128.94
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	852.31	141.99
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	873.54	125.68
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	671.96	105.02
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	970.19	151.83
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	653.51	103.41
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	493.70	77.68
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	772.91	100.33
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	435.05	65.47
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	673.91	95.05
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	783.30	106.28
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	589.43	104.98
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	699.62	100.96
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	790.21	128.89
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	558.22	95.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	661.91	101.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	793.41	123.72
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	593.09	76.75
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	758.40	120.58
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	707.87	109.64
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	945.66	189.71
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1251.72	146.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	1131.58	151.44
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	748.98	131.73
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	822.62	100.06
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	840.86	135.19
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	600.67	82.61
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	653.32	66.36
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	725.35	104.79
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	591.78	81.15
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	718.19	78.36
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	695.29	90.14
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	479.15	86.66
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	620.95	77.73
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	703.54	105.69
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	452.68	103.30
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	593.09	62.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	697.30	97.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	352.42	61.98
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	564.43	113.44
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	633.06	92.72
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	507.12	92.96
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	513.96	122.74
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	587.85	96.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	658.90	137.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	769.48	158.61
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	796.03	132.67
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	621.06	107.52
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	691.77	153.22
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	791.70	143.11
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	672.63	108.06
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	609.20	142.80
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	865.62	137.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	686.44	100.36
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	636.76	140.61
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	929.82	123.65
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	629.58	118.39
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	598.37	168.93
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	852.52	121.95
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	624.26	105.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	555.93	112.72
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	651.69	95.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	682.64	79.03
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	653.16	135.94
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	1137.00	49.89
Macrophage - monocyte derived, donor1	11232-116C8	47.41	4.33
Macrophage - monocyte derived, donor2	11313-117C8	28.81	4.59
Macrophage - monocyte derived, donor3	11389-118C3	93.72	10.09
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	83.37	7.97
Mallassez-derived cells, donor2	11929-125I3	15.37	2.22
Mallassez-derived cells, donor3	11930-125I4	50.73	8.20
Mammary Epithelial Cell, donor1	11273-116H4	475.00	39.26
Mammary Epithelial Cell, donor2	11350-117G9	278.84	44.30
Mammary Epithelial Cell, donor3	11422-118F9	541.26	67.10
Mast cell - stimulated, donor1	11487-119E2	44.07	18.98
Mast cell, donor1	11563-120D6	113.12	13.19
Mast cell, donor2	11565-120D8	99.55	13.67
Mast cell, donor3	11566-120D9	129.45	16.66
Mast cell, donor4	11567-120E1	90.59	12.06
Mast cell, expanded and stimulated, donor5	11940-126A5	132.30	14.64
Mast cell, expanded and stimulated, donor8	11942-126A7	235.22	30.35
Mast cell, expanded, donor5	11939-126A4	344.74	39.23
Mast cell, expanded, donor8	11941-126A6	305.28	40.50
Melanocyte - dark, donor1	11502-119F8	174.02	19.60
Melanocyte - dark, donor2	11582-120F7	127.01	26.30
Melanocyte - dark, donor3	11663-122F7	172.84	23.33
Melanocyte - light, donor1	11274-116H5	106.96	12.93
Melanocyte - light, donor2	11351-117H1	211.56	47.77
Melanocyte - light, donor3	11423-118G1	260.17	57.24
Melanocyte, donor1 (MC+1)	12641-134G4	160.14	15.72
Melanocyte, donor2 (MC+2)	12739-135I3	183.15	31.20
Melanocyte, donor3 (MC+3)	12837-137B2	29.46	2.95
Meningeal Cells, donor1	11493-119E8	202.22	62.03
Meningeal Cells, donor2	11573-120E7	95.51	23.33
Meningeal Cells, donor3	11654-122E7	527.15	53.30
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	273.46	22.24
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	20.13	2.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	35.48	6.57
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	289.10	48.40
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	316.46	53.10
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.00	3.60
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	40.21	8.04
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	215.80	35.16
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	392.33	57.72
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	336.57	40.51
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	16.90	6.51
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	60.22	5.58
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	40.66	4.34
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.78	3.26
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	58.39	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	152.42	24.34
Mesenchymal stem cells - adipose, donor0	11217-116B2	239.60	27.29
Mesenchymal stem cells - hepatic, donor0	11218-116B3	45.34	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	553.70	99.42
Mesothelial Cells, donor1	11247-116E5	15.11	1.06
Mesothelial Cells, donor2	12156-128G5	14.01	2.00
Mesothelial Cells, donor3	11402-118D7	20.31	2.24
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	39.16	14.28
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	32.39	4.42
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	47.42	9.30
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	30.91	2.49
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	34.54	7.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.15	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	24.79	6.10
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	25.74	3.56
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	37.17	12.39
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	28.50	5.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	29.07	8.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.84	4.17
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	19.82	6.27
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.01	4.28
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.73	3.68
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	15.14	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	15.29	2.04
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	20.17	4.72
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	17.78	3.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.20	1.75
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.55	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	9.78	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.35	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	19.70	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	15.21	2.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.02	2.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.88	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.40	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.30	4.10
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.75	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.26	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	14.87	2.52
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3.33	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.91	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.95	1.51
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.19	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	14.23	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.05	1.24
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.99	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.27	1.87
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	9.88	2.69
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.89	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	17.20	2.87
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	6.63	1.77
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	5.31	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.76	2.56
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	14.01	2.95
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	14.70	3.53
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	12.11	2.59
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	27.20	3.71
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.29	2.68
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	75.34	15.07
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	103.37	12.48
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	77.87	10.51
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	55.75	13.68
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	65.24	8.11
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	33.53	3.73
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	39.43	7.14
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	27.43	4.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.83	3.96
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	39.78	5.16
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	55.33	7.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	31.11	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	28.86	4.28
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	77.28	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	103.01	30.30
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	37.95	5.06
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	157.99	14.98
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	91.55	13.35
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	136.05	20.25
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	132.92	21.15
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	239.83	51.39
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	225.11	16.31
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	163.14	25.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	42.01	6.25
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	31.88	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	127.49	13.35
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	100.17	11.69
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	346.82	54.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	205.87	47.88
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	63.23	5.44
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	108.42	23.89
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	64.45	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	116.68	18.60
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	39.99	6.22
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	50.67	9.67
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	24.32	3.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.71	7.58
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	26.75	3.17
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	25.80	3.10
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	41.37	7.29
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.22	3.18
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	21.01	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	27.57	6.56
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.47	1.95
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.22	3.17
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	32.35	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	17.93	3.68
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	19.28	1.93
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.73	5.17
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	45.51	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.72	2.23
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.51	2.96
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.56	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	22.32	2.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.33	3.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.49	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.08	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	24.14	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	36.32	6.43
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.87	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.69	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.35	3.62
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	6.17
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.95	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	20.83	3.97
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.98	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	23.29	5.14
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	17.02	3.98
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	13.55	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	22.56	3.66
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	8.81	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.32	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	37.97	3.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	6.80
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	0.00
Myoblast, donor1	11241-116D8	22.86	1.86
Myoblast, donor2	11322-117D8	56.77	8.82
Myoblast, donor3	11398-118D3	58.18	4.88
NK T cell leukemia cell line:KHYG-1	10777-110G3	680.48	54.58
Natural Killer Cells, donor1	11230-116C6	235.25	31.37
Natural Killer Cells, donor2	11311-117C6	406.20	76.29
Natural Killer Cells, donor3	11387-118C1	316.94	43.07
Neural stem cells, donor1	11275-116H6	234.46	39.20
Neural stem cells, donor2	11352-117H2	105.91	26.96
Neurons, donor1	11494-119E9	897.80	235.54
Neurons, donor2	11574-120E8	568.68	66.71
Neurons, donor3	11655-122E8	1466.74	191.56
Neutrophils, donor1	11233-116C9	17.63	2.78
Neutrophils, donor2	11314-117C9	23.19	5.80
Neutrophils, donor3	11390-118C4	28.10	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	57.82	3.68
Nucleus Pulposus Cell, donor2	11409-118E5	72.94	3.91
Nucleus Pulposus Cell, donor3	11462-119B4	46.73	16.65
Olfactory epithelial cells, donor1	11933-125I7	35.24	2.62
Olfactory epithelial cells, donor2	11934-125I8	43.13	5.36
Olfactory epithelial cells, donor3	11935-125I9	25.65	1.93
Olfactory epithelial cells, donor4	11936-126A1	41.39	4.38
Oligodendrocyte - precursors, donor1	11496-119F2	99.90	16.85
Osteoblast - differentiated, donor1	11276-116H7	39.56	6.81
Osteoblast - differentiated, donor2	11353-117H3	69.73	22.86
Osteoblast - differentiated, donor3	11425-118G3	129.11	30.41
Osteoblast, donor1	11277-116H8	758.69	76.81
Osteoblast, donor2	11354-117H4	117.99	10.53
Osteoblast, donor3	11426-118G4	243.49	25.59
Pancreatic stromal cells, donor1	11249-116E7	116.75	10.36
Pericytes, donor1	11491-119E6	52.41	14.80
Pericytes, donor2	11571-120E5	67.00	13.36
Pericytes, donor3	11652-122E5	100.50	12.82
Perineurial Cells, donor1	11499-119F5	104.09	13.45
Perineurial Cells, donor2	11579-120F4	91.09	12.15
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	92.12	11.16
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	178.01	32.57
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	119.84	13.98
Placental Epithelial Cells, donor1	11278-116H9	314.50	35.87
Placental Epithelial Cells, donor2	11355-117H5	341.54	51.01
Placental Epithelial Cells, donor3	11427-118G5	323.15	56.93
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	29.75	3.48
Preadipocyte - breast, donor1	11467-119B9	0.19	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	10.05	0.78
Preadipocyte - breast, donor2	11328-117E5	14.41	2.48
Preadipocyte - omental, donor1	11468-119C1	2.56	0.32
Preadipocyte - omental, donor2	11329-117E6	8.73	1.75
Preadipocyte - omental, donor3	11403-118D8	3.72	0.57
Preadipocyte - perirenal, donor1	11469-119C2	3.94	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	486.17	43.00
Preadipocyte - subcutaneous, donor2	11356-117H6	339.81	33.11
Preadipocyte - subcutaneous, donor3	11428-118G6	125.16	12.94
Preadipocyte - visceral, donor1	11280-116I2	181.82	17.51
Preadipocyte - visceral, donor2	11357-117H7	132.53	26.23
Preadipocyte - visceral, donor3	11429-118G7	231.24	35.53
Prostate Epithelial Cells (polarized), donor1	11253-116F2	213.46	28.06
Prostate Epithelial Cells, donor2	11331-117E8	41.98	7.58
Prostate Epithelial Cells, donor3	11404-118D9	38.89	2.51
Prostate Stromal Cells, donor1	11254-116F3	259.12	23.81
Prostate Stromal Cells, donor2	11332-117E9	334.57	50.74
Prostate Stromal Cells, donor3	11405-118E1	28.15	2.40
Renal Cortical Epithelial Cells, donor1	11516-119H4	86.87	12.77
Renal Cortical Epithelial Cells, donor2	11596-120H3	112.01	12.89
Renal Epithelial Cells, donor1	11517-119H5	385.50	64.93
Renal Epithelial Cells, donor2	11597-120H4	312.98	47.66
Renal Epithelial Cells, donor3	11678-122H4	114.55	14.08
Renal Glomerular Endothelial Cells, donor1	11514-119H2	184.51	70.81
Renal Glomerular Endothelial Cells, donor2	11594-120H1	203.63	58.62
Renal Glomerular Endothelial Cells, donor3	11675-122H1	343.45	81.70
Renal Glomerular Endothelial Cells, donor4	11783-124B1	131.76	25.29
Renal Mesangial Cells, donor1	11518-119H6	117.53	17.39
Renal Mesangial Cells, donor2	11598-120H5	122.26	20.69
Renal Mesangial Cells, donor3	11679-122H5	118.18	17.48
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	136.09	19.06
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	202.41	31.63
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	299.30	42.43
Retinal Pigment Epithelial Cells, donor0	11215-116A9	193.42	21.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	79.87	14.78
Retinal Pigment Epithelial Cells, donor2	11608-120I6	363.28	61.75
Retinal Pigment Epithelial Cells, donor3	11689-122I6	65.24	7.53
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	25.93	3.88
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	172.43	16.08
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	237.76	22.01
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	179.24	19.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	223.51	50.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	261.07	40.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	324.47	33.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	219.43	40.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	298.47	47.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	297.70	40.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	153.34	39.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	247.94	42.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	289.03	26.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	151.49	40.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	241.14	28.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	240.74	31.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	154.28	41.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	179.15	26.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	191.48	24.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	159.51	38.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	207.53	23.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	263.91	30.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	197.67	48.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	227.89	41.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	256.69	51.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	204.94	55.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	218.90	30.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	319.68	49.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	249.08	73.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	256.75	35.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	359.19	51.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	256.29	68.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	251.29	45.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	271.76	33.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	195.69	49.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	203.67	24.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	261.04	30.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	216.47	56.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	193.82	24.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	349.52	42.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	168.22	48.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	271.50	33.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	248.69	30.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	160.25	51.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	340.49	44.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	274.70	32.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	258.51	81.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	320.71	48.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	212.15	24.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	228.99	62.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	115.28	13.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	368.10	32.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	244.13	78.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	200.63	29.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	222.26	26.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	226.58	40.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	233.72	35.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	269.84	32.45
Schwann Cells, donor1	11498-119F4	412.63	126.20
Schwann Cells, donor2	11578-120F3	398.08	54.44
Schwann Cells, donor3	11659-122F3	252.16	57.62
Sebocyte, donor1	11220-116B5	52.04	3.29
Sebocyte, donor2	11301-117B5	68.93	7.35
Sebocyte, donor3	11378-118B1	38.96	5.36
Sertoli Cells, donor1	11255-116F4	76.20	6.63
Sertoli Cells, donor2	11333-117F1	25.42	14.12
Skeletal Muscle Cells, donor1	11281-116I3	174.55	16.63
Skeletal Muscle Cells, donor2	11358-117H8	173.48	26.02
Skeletal Muscle Cells, donor3	11430-118G8	3511.36	769.99
Skeletal Muscle Cells, donor4	11451-119A2	359.12	67.24
Skeletal Muscle Cells, donor5	11455-119A6	338.76	66.00
Skeletal Muscle Cells, donor6	11459-119B1	373.98	78.64
Skeletal Muscle Satellite Cells, donor1	11240-116D7	146.29	16.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	129.28	20.55
Skeletal Muscle Satellite Cells, donor3	11397-118D2	342.67	54.07
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	110.62	10.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2685.89	336.55
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	152.46	27.38
Skin - palm, donor1	10286-104F7	24.17	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	67.32	8.51
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.00	4.91
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	110.35	14.15
Small Airway Epithelial Cells, donor1	11256-116F5	63.80	7.23
Small Airway Epithelial Cells, donor2	11334-117F2	75.25	9.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	49.48	4.65
Small Airway Epithelial Cells, donor3	11406-118E2	42.57	4.57
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	27.16	7.71
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.23	2.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	320.95	33.51
Smooth Muscle Cells - Aortic, donor1	11283-116I5	86.19	6.41
Smooth Muscle Cells - Aortic, donor2	11360-117I1	113.80	12.60
Smooth Muscle Cells - Aortic, donor3	11432-118H1	346.11	44.81
Smooth Muscle Cells - Bladder, donor1	11519-119H7	49.04	5.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	72.93	5.86
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	45.88	8.64
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	82.84	18.44
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	73.26	6.84
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	71.76	9.75
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	18.51	1.42
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	92.40	15.94
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.62	7.31
Smooth Muscle Cells - Carotid, donor1	11285-116I7	334.39	36.37
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	18.36
Smooth Muscle Cells - Carotid, donor3	11434-118H3	337.60	73.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	84.80	9.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	94.92	15.50
Smooth Muscle Cells - Colonic, donor3	11396-118D1	136.76	13.01
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	168.14	17.17
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	51.74	11.86
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	99.22	13.75
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	223.62	23.56
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	49.32	5.97
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	14.19	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	22.53	3.87
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	129.82	40.46
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	533.56	63.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	90.95	16.11
Smooth Muscle Cells - Prostate, donor2	11335-117F3	50.09	8.51
Smooth Muscle Cells - Prostate, donor3	11465-119B7	13.19	2.03
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	159.07	13.12
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	149.28	24.01
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	103.38	28.43
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	596.69	58.60
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	98.96	12.12
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	37.92	7.83
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	14.75	2.36
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	206.02	22.49
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.64	6.54
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	91.82	8.49
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	420.17	47.68
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	405.21	81.23
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	143.24	14.95
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	30.50	4.02
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	41.43	9.05
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	64.35	6.36
Smooth Muscle Cells - Uterine, donor1	11258-116F7	15.91	2.65
Smooth Muscle Cells - Uterine, donor3	11466-119B8	521.08	56.18
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	14.97	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	4.76	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	31.99	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.98	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	17.89	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	196.15	16.94
Smooth muscle cells - airway, control, donor1	11966-126D4	20.06	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	25.96	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	17.97	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	25.21	3.67
Synoviocyte, donor1	11291-117A4	37.20	2.36
Synoviocyte, donor2	11368-117I9	19.44	2.85
Synoviocyte, donor3	11440-118H9	4.92	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	324.81	47.88
Trabecular Meshwork Cells, donor2	11612-122A1	184.33	41.62
Trabecular Meshwork Cells, donor3	11693-123A1	795.83	101.65
Tracheal Epithelial Cells, donor1	11292-117A5	298.85	39.57
Tracheal Epithelial Cells, donor2	11369-118A1	642.08	67.26
Tracheal Epithelial Cells, donor3	11441-118I1	1254.70	257.13
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.54	4.18
Urethra, donor2	10319-105A4	34.17	8.99
Urothelial Cells, donor1	11520-119H8	20.99	8.24
Urothelial Cells, donor2	11600-120H7	34.85	4.81
Urothelial Cells, donor3	11681-122H7	32.32	5.96
Urothelial cells, donor0	11216-116B1	16.05	2.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	80.08	21.35
Whole blood (ribopure), donor090309, donation2	12180-129A2	55.75	28.59
Whole blood (ribopure), donor090309, donation3	12181-129A3	76.67	6.85
Whole blood (ribopure), donor090325, donation1	12176-128I7	77.82	6.89
Whole blood (ribopure), donor090325, donation2	12177-128I8	74.95	8.72
Whole blood (ribopure), donor090612, donation1	12182-129A4	51.02	8.33
Whole blood (ribopure), donor090612, donation2	12183-129A5	53.23	18.36
Whole blood (ribopure), donor090612, donation3	12184-129A6	105.90	21.91
Wilms' tumor cell line:G-401	10809-111A8	289.90	21.34
Wilms' tumor cell line:HFWT	10597-108E3	24.64	4.40
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	414.79	59.49
achilles tendon, donor2	10292-104G4	18.60	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	569.32	66.03
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1198.25	111.44
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	1371.31	127.85
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	386.67	46.53
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	491.62	95.57
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	1448.65	171.51
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	369.39	65.33
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	267.47	49.79
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	268.29	51.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	570.02	37.66
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	319.61	60.54
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	483.66	101.41
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	402.95	90.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	582.79	116.25
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	398.62	81.24
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	357.86	70.64
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	477.88	122.96
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	176.19	26.70
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	334.54	30.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	222.01	11.83
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	275.61	30.33
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	558.02	111.74
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	278.73	52.03
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	465.18	85.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	595.76	129.97
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	88.10	9.37
adenocarcinoma cell line:IM95m	10796-110I4	184.16	17.19
adipose tissue, adult, pool1	10010-101C1	15.98	3.10
adipose, donor1	10184-103D4	878.44	123.15
adipose, donor2	10185-103D5	724.66	61.23
adipose, donor3	10186-103D6	840.83	76.51
adipose, donor4	10187-103D7	388.30	69.34
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	182.12	12.15
adrenal gland, adult, pool1	10081-102A9	25.46	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	197.71	19.88
alveolar cell carcinoma cell line:SW 1573	10708-109H6	399.46	46.81
amniotic membrane cells, donor1	12235-129G3	105.72	15.53
amniotic membrane cells, donor2	12236-129G4	191.03	33.47
amniotic membrane cells, donor3	12237-129G5	48.61	7.95
amygdala - adult, donor10196	10167-103B5	29.64	4.74
amygdala, adult, donor10252	10151-102I7	39.74	4.06
amygdala, newborn, donor10223	10360-105E9	103.29	12.91
anaplastic carcinoma cell line:8305C	10428-106D5	69.01	9.04
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	465.96	34.42
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	540.14	44.76
aorta, adult, pool1	10052-101G7	48.84	6.08
appendix, adult	10189-103D9	361.73	66.76
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	255.20	45.40
artery, adult	10190-103E1	6.79	0.00
astrocytoma cell line:TM-31	10425-106D2	170.07	17.96
b cell line:RPMI1788	10427-106D4	395.69	39.55
basal cell carcinoma cell line:TE 354.T	10702-109G9	25.25	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	142.50	15.08
bile duct carcinoma cell line:TFK-1	10496-107C1	44.19	6.19
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	658.78	91.16
bladder, adult, pool1	10011-101C2	41.94	6.30
blood, adult, pool1	10053-101G8	236.97	24.36
bone marrow stromal cell line:StromaNKtert	10686-109F2	61.66	4.28
bone marrow, adult	10192-103E3	45.89	6.75
brain, adult, donor1	10084-102B3	55.35	10.25
brain, adult, pool1	10012-101C3	52.12	10.13
brain, fetal, pool1	10085-102B4	507.57	42.74
breast carcinoma cell line:MCF7	10482-107A5	199.21	29.73
breast carcinoma cell line:MDA-MB-453	10419-106C5	130.81	12.98
breast, adult, donor1	10080-102A8	34.09	4.42
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	86.77	7.50
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	121.77	18.64
carcinoid cell line:NCI-H1770	10703-109H1	362.50	53.60
carcinoid cell line:NCI-H727	10735-110B6	341.05	32.81
carcinoid cell line:SK-PN-DW	10719-109I8	46.90	8.87
carcinosarcoma cell line:JHUCS-1	10642-109A3	7.19	2.13
caudate nucleus - adult, donor10196	10177-103C6	19.57	6.91
caudate nucleus, adult, donor10252	10164-103B2	30.96	4.52
caudate nucleus, adult, donor10258	10379-105H1	30.57	5.35
caudate nucleus, newborn, donor10223	10354-105E3	220.11	23.07
cerebellum - adult, donor10196	10173-103C2	110.70	26.22
cerebellum, adult, donor10252	10166-103B4	74.30	11.96
cerebellum, adult, pool1	10083-102B2	145.22	30.01
cerebellum, newborn, donor10223	10357-105E6	297.24	35.70
cerebral meninges, adult	10188-103D8	68.83	14.12
cerebrospinal fluid, donor2	10294-104G6	15.35	4.39
cervical cancer cell line:D98-AH2	10552-107I3	136.88	14.52
cervical cancer cell line:ME-180	10553-107I4	129.09	16.07
cervix, adult, pool1	10013-101C4	81.05	15.33
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	55.46	6.55
chondrosarcoma cell line:SW 1353	10700-109G7	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	245.20	26.72
choriocarcinoma cell line:SCH	10785-110H2	135.41	8.26
choriocarcinoma cell line:T3M-3	10618-108G6	109.34	16.37
chorionic membrane cells, donor1	12238-129G6	127.36	18.80
chorionic membrane cells, donor2	12239-129G7	93.76	12.73
chorionic membrane cells, donor3	12240-129G8	65.39	10.99
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1690.41	515.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	388.04	32.85
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	234.63	21.96
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	270.92	73.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	283.00	79.34
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	258.18	62.92
chronic myelogenous leukemia cell line:K562	10454-106G4	626.90	80.09
chronic myelogenous leukemia cell line:KU812	10409-106B4	792.56	84.18
clear cell carcinoma cell line:JHOC-5	10638-108I8	471.79	69.49
clear cell carcinoma cell line:TEN	10636-108I6	293.92	37.82
colon carcinoma cell line:CACO-2	10513-107D9	290.30	30.20
colon carcinoma cell line:COLO-320	10420-106C6	570.50	69.55
colon, adult, donor1	10082-102B1	283.23	28.56
colon, adult, pool1	10014-101C5	78.61	11.87
colon, fetal, donor1	10070-101I7	416.52	57.47
common myeloid progenitor CMP, donor1	12130-128D6	100.84	4.58
common myeloid progenitor CMP, donor2	12134-128E1	2153.16	175.26
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1477.07	213.32
cord blood derived cell line:COBL-a 24h infection	10453-106G3	539.73	64.60
cord blood derived cell line:COBL-a untreated	10449-106F8	500.45	51.47
corpus callosum, adult, pool1	10042-101F6	25.76	3.43
cruciate ligament, donor2	10295-104G7	25.94	4.05
diaphragm, fetal, donor1	10069-101I6	64.21	12.84
diencephalon, adult	10193-103E4	35.76	7.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1643.10	242.47
ductal cell carcinoma cell line:KLM-1	10438-106E6	145.91	14.87
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	62.83	9.63
ductus deferens, adult	10196-103E7	65.28	9.97
duodenum, fetal, donor1, tech_rep1	10071-101I8	260.68	31.69
duodenum, fetal, donor1, tech_rep2	10071-101I8	168.46	38.99
dura mater, adult, donor1	10041-101F5	78.79	10.57
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	2220.95	303.35
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	701.28	94.14
embryonic pancreas cell line:1B2C6	10604-108F1	85.09	12.95
embryonic pancreas cell line:1C3D3	10605-108F2	50.86	4.54
embryonic pancreas cell line:1C3IKEI	10606-108F3	73.48	8.64
embryonic pancreas cell line:2C6	10603-108E9	77.49	14.45
endometrial carcinoma cell line:OMC-2	10497-107C2	45.25	4.36
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	119.07	15.59
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	81.05	15.28
epidermoid carcinoma cell line:A431	10426-106D3	221.54	27.01
epidermoid carcinoma cell line:Ca Ski	10431-106D8	197.53	21.56
epididymis, adult	10197-103E8	73.68	11.93
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	133.06	17.03
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	46.40	3.54
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	545.30	58.58
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	758.72	80.90
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	403.19	46.94
esophagus, adult, pool1	10015-101C6	107.24	16.88
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	150.03	18.53
eye - muscle inferior rectus, donor1	10272-104E2	19.32	4.83
eye - muscle lateral, donor2	10298-104H1	4.21	0.00
eye - muscle medial, donor2	10299-104H2	1.49	0.00
eye - muscle superior, donor2	10297-104G9	33.25	3.44
eye - vitreous humor, donor1	10268-104D7	61.21	5.83
eye, fetal, donor1	10054-101G9	178.73	31.53
fibrosarcoma cell line:HT-1080	10758-110E2	116.43	9.23
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	340.70	54.37
frontal lobe, adult, pool1	10040-101F4	31.24	5.44
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	320.37	45.04
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	0.91	0.37
gall bladder, adult	10198-103E9	48.77	8.21
gamma delta positive T cells, donor1	11937-126A2	241.05	20.94
gamma delta positive T cells, donor2	11938-126A3	289.46	31.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	253.04	39.08
gastric adenocarcinoma cell line:MKN45	10612-108F9	97.48	15.28
gastric cancer cell line:AZ521	10549-107H9	291.35	29.68
gastric cancer cell line:GSS	10560-108A2	268.16	43.93
gastrointestinal carcinoma cell line:ECC12	10615-108G3	182.99	32.67
giant cell carcinoma cell line:LU65	10487-107B1	30.87	2.87
giant cell carcinoma cell line:Lu99B	10433-106E1	1.12	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	77.32	12.22
glioblastoma cell line:A172, tech_rep1	10444-106F3	137.53	18.26
glioblastoma cell line:A172, tech_rep2	10444-106F3	150.13	19.80
glioblastoma cell line:T98G	10485-107A8	385.20	42.94
glioma cell line:GI-1	10413-106B8	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	16.04	4.37
globus pallidus, adult, donor10252	10161-103A8	20.50	2.69
globus pallidus, adult, donor10258	10367-105F7	42.45	10.95
globus pallidus, newborn, donor10223	10364-105F4	108.72	6.40
granulocyte macrophage progenitor, donor1	12131-128D7	97.89	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	1355.12	98.36
granulocyte macrophage progenitor, donor3	12139-128E6	1317.10	162.02
granulosa cell tumor cell line:KGN	10624-108H3	69.76	9.28
hIPS +CCl2, biol_rep1	14383-156B9	269.96	50.96
hIPS +CCl2, biol_rep2	14384-156C1	208.97	59.90
hIPS +CCl2, biol_rep3	14385-156C2	140.41	57.97
hIPS, biol_rep1	14380-156B6	70.43	109.23
hIPS, biol_rep2	14381-156B7	113.85	46.64
hIPS, biol_rep3	14382-156B8	38.62	15.45
hairy cell leukemia cell line:Mo	10712-109I1	431.59	54.31
heart - mitral valve, adult	10205-103F7	19.13	3.59
heart - pulmonic valve, adult	10206-103F8	15.43	2.35
heart - tricuspid valve, adult	10207-103F9	11.66	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	28.57	4.29
heart, adult, diseased, donor1	10051-101G6	22.57	3.83
heart, adult, pool1	10016-101C7	25.53	2.99
heart, fetal, pool1	10046-101G1	63.25	9.75
hepatic mesenchymal tumor cell line:LI90	10778-110G4	7.10	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	271.13	48.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	600.43	82.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	637.82	87.03
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	651.79	72.05
hepatoma cell line:Li-7	10484-107A7	91.75	9.23
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	667.12	47.54
hippocampus - adult, donor10196	10169-103B7	26.50	7.57
hippocampus, adult, donor10252	10153-102I9	33.06	5.51
hippocampus, adult, donor10258	10374-105G5	6.97	6.47
hippocampus, newborn, donor10223	10363-105F3	168.84	18.68
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1013.17	135.50
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	859.25	103.28
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	780.98	87.34
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1079.80	105.44
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1558.56	191.59
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	1305.48	134.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	1201.39	141.01
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1175.81	125.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1091.06	117.20
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	1727.88	171.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	1716.94	189.65
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	1696.72	148.80
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	673.35	72.61
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	954.58	171.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1075.23	135.28
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1021.75	116.46
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	803.68	108.58
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1201.93	140.43
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	678.96	94.76
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	708.00	102.31
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	776.51	87.39
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	1002.67	107.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	777.74	113.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	969.71	92.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	604.48	70.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	479.56	66.47
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	697.80	87.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	571.43	101.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	469.41	72.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	636.11	64.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	370.78	57.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	430.38	79.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	521.02	54.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	575.21	82.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	615.62	121.16
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	718.49	61.50
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	185.48	34.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	271.85	21.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	201.95	26.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	16.81	4.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	22.84	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	18.06	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.63	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.22	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	16.66	1.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	21.01	3.23
immature langerhans cells, donor1	11904-125F5	116.47	12.83
immature langerhans cells, donor2	11905-125F6	198.03	23.76
insula, adult, pool1	10039-101F3	38.14	6.72
keratoacanthoma cell line:HKA-1	10791-110H8	206.14	23.09
kidney, adult, pool1	10017-101C8	17.42	2.60
kidney, fetal, pool1	10045-101F9	165.17	22.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	21.45	2.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	89.30	5.39
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	91.38	13.58
left atrium, adult, donor1	10079-102A7	45.77	7.08
left ventricle, adult, donor1	10078-102A6	24.78	3.54
leiomyoblastoma cell line:G-402	10721-110A1	12.31	1.09
leiomyoma cell line:10964C	10569-108B2	35.57	3.59
leiomyoma cell line:15242A	10570-108B3	21.20	5.43
leiomyoma cell line:15425	10571-108B4	66.77	10.68
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	149.51	17.77
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	170.36	20.31
liposarcoma cell line:KMLS-1	10782-110G8	41.24	3.91
liposarcoma cell line:SW 872	10726-110A6	0.12	0.00
liver, adult, pool1	10018-101C9	9.72	0.97
liver, fetal, pool1	10086-102B5	817.48	92.19
locus coeruleus - adult, donor10196	10182-103D2	29.02	5.10
locus coeruleus, adult, donor10252	10165-103B3	21.22	3.32
locus coeruleus, adult, donor10258	10375-105G6	36.96	6.77
locus coeruleus, newborn, donor10223	10362-105F2	108.52	11.78
lung adenocarcinoma cell line:A549	10499-107C4	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	48.26	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	28.60	4.22
lung, adult, pool1	10019-101D1	51.86	6.50
lung, fetal, donor1	10068-101I5	80.20	27.68
lung, right lower lobe, adult, donor1	10075-102A3	52.24	6.87
lymph node, adult, donor1	10077-102A5	144.85	14.67
lymphangiectasia cell line:DS-1	10727-110A7	276.38	18.85
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	563.71	65.35
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	118.93	17.84
mature adipocyte, donor1	12231-129F8	4.88	0.89
mature adipocyte, donor2	12232-129F9	7.26	1.66
mature adipocyte, donor3	12233-129G1	3.56	0.71
mature adipocyte, donor4	12234-129G2	10.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	303.54	27.16
medial frontal gyrus - adult, donor10196	10170-103B8	47.38	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	46.71	8.46
medial frontal gyrus, adult, donor10258	10368-105F8	53.05	6.67
medial frontal gyrus, newborn, donor10223	10352-105E1	67.39	15.35
medial temporal gyrus - adult, donor10196	10183-103D3	70.88	12.99
medial temporal gyrus, adult, donor10252	10156-103A3	41.81	6.37
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	125.63	13.64
medulla oblongata - adult, donor10196	10174-103C3	24.66	7.14
medulla oblongata, adult, donor10252	10155-103A2	21.67	5.26
medulla oblongata, adult, pool1	10038-101F2	16.41	3.10
medulla oblongata, newborn, donor10223	10361-105F1	62.84	5.55
medulloblastoma cell line:D283 Med	10838-111E1	687.48	71.74
medulloblastoma cell line:ONS-76	10759-110E3	241.00	15.04
melanoma cell line:COLO 679	10514-107E1	89.41	11.93
melanoma cell line:G-361	10465-106H6	40.99	3.53
meningioma cell line:HKBMM	10691-109F7	83.58	13.39
merkel cell carcinoma cell line:MKL-1	10843-111E6	991.30	167.42
merkel cell carcinoma cell line:MS-1	10844-111E7	1182.06	166.16
mesenchymal precursor cell - adipose, donor1	11747-123G1	91.45	17.95
mesenchymal precursor cell - adipose, donor2	11748-123G2	37.81	5.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	41.41	14.49
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	19.25	3.51
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.13	1.93
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.27	4.16
mesenchymal precursor cell - cardiac, donor1	11752-123G6	8.92	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	17.48	3.68
mesenchymal precursor cell - cardiac, donor3	11754-123G8	67.38	14.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	201.75	38.89
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	77.68	14.51
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	7.58	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	113.33	21.45
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	61.09	11.52
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	18.78	3.88
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.85	4.31
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	25.45	5.69
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.66	2.28
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	119.57	24.33
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	63.06	13.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	30.11	4.81
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	17.67	3.68
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	35.20	4.01
mesenchymal stem cell line:Hu5/E18	10568-108B1	171.35	32.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	40.64	6.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	32.23	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	42.14	5.50
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	31.12	6.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	33.19	3.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	36.55	7.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	34.19	5.50
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	42.63	6.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	38.94	6.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	30.79	4.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	28.12	5.77
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	34.47	6.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	33.57	4.70
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	40.53	5.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	36.08	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	51.65	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	49.37	3.90
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	33.46	7.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	53.84	7.46
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	44.16	5.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	53.25	7.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	65.06	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	35.76	9.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	47.44	4.15
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	62.14	7.31
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	49.40	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	32.42	4.48
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.56	3.26
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.86	6.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.69	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	20.26	2.81
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	24.06	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	24.09	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.85	2.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	16.54	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	15.72	2.42
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	8.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.28	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	23.22	2.18
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.47	2.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	18.34	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	85.99	8.98
mesothelioma cell line:ACC-MESO-4	10494-107B8	167.73	25.02
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	106.84	21.37
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	347.09	31.03
mesothelioma cell line:Mero-25	10850-111F4	233.76	44.94
mesothelioma cell line:Mero-41	10851-111F5	44.49	9.53
mesothelioma cell line:Mero-48a	10852-111F6	47.83	7.75
mesothelioma cell line:Mero-82	10853-111F7	218.13	31.01
mesothelioma cell line:Mero-83	10854-111F8	40.68	5.79
mesothelioma cell line:Mero-84	10855-111F9	146.36	26.29
mesothelioma cell line:Mero-95	10856-111G1	122.16	19.88
mesothelioma cell line:NCI-H2052	10847-111F1	50.52	8.61
mesothelioma cell line:NCI-H226	10846-111E9	118.91	20.81
mesothelioma cell line:NCI-H2452	10848-111F2	156.81	32.97
mesothelioma cell line:NCI-H28	10845-111E8	127.49	28.75
mesothelioma cell line:No36	10857-111G2	206.16	45.34
mesothelioma cell line:ONE58	10858-111G3	63.94	9.75
migratory langerhans cells, donor1	11901-125F2	55.08	5.95
migratory langerhans cells, donor2	11902-125F3	53.12	6.84
migratory langerhans cells, donor3	11903-125F4	35.54	4.13
mixed mullerian tumor cell line:HTMMT	10689-109F5	116.55	18.28
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	236.73	22.47
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	154.11	14.51
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	363.27	23.79
myelodysplastic syndrome cell line:SKM-1	10772-110F7	836.92	99.97
myeloma cell line:PCM6	10474-106I6	181.26	19.17
myxofibrosarcoma cell line:MFH-ino	10600-108E6	154.22	27.90
myxofibrosarcoma cell line:NMFH-1	10684-109E9	183.39	28.44
nasal epithelial cells, donor1, tech_rep1	12226-129F3	34.99	3.01
nasal epithelial cells, donor1, tech_rep2	12226-129F3	52.66	6.10
nasal epithelial cells, donor2	12227-129F4	53.54	11.59
neuroblastoma cell line:CHP-134	10508-107D4	714.34	66.26
neuroblastoma cell line:NB-1	10539-107G8	307.01	42.28
neuroblastoma cell line:NBsusSR	10607-108F4	468.81	74.87
neuroblastoma cell line:NH-12	10555-107I6	1189.11	200.33
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	331.17	39.62
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	533.90	78.87
neuroectodermal tumor cell line:TASK1	10774-110F9	245.94	22.14
neuroepithelioma cell line:SK-N-MC	10728-110A8	197.09	18.44
neurofibroma cell line:Hs 53.T	10729-110A9	40.72	2.66
neutrophil PMN, donor1	12133-128D9	14.87	14.87
neutrophil PMN, donor2	12137-128E4	239.05	26.56
neutrophil PMN, donor3	12141-128E8	322.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	748.36	88.11
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	628.40	56.04
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	65.40	5.13
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	75.94	15.77
nucleus accumbens, adult, pool1	10037-101F1	22.03	3.75
occipital cortex - adult, donor10196	10172-103C1	63.87	8.24
occipital cortex, adult, donor10252	10163-103B1	39.18	6.98
occipital cortex, newborn, donor10223	10355-105E4	173.97	17.11
occipital lobe, adult, donor1	10076-102A4	107.58	19.42
occipital lobe, fetal, donor1	10073-102A1	843.18	108.56
occipital pole, adult, pool1	10036-101E9	41.31	7.73
olfactory region, adult	10195-103E6	56.36	12.42
optic nerve, donor1	10277-104E7	30.02	18.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	38.61	3.30
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	115.54	19.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	153.92	25.91
oral squamous cell carcinoma cell line:SAS	10544-107H4	282.07	37.77
osteoclastoma cell line:Hs 706.T	10704-109H2	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	256.94	38.31
osteosarcoma cell line:HS-Os-1	10558-107I9	58.32	7.00
ovary, adult, pool1	10020-101D2	42.54	6.81
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	0.00	0.00
pancreas, adult, donor1	10049-101G4	28.22	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	203.57	32.37
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	96.70	9.27
paracentral gyrus, adult, pool1	10035-101E8	23.34	4.21
parietal cortex, adult, donor10258	10373-105G4	23.49	2.20
parietal lobe - adult, donor10196	10171-103B9	31.04	6.58
parietal lobe, adult, donor10252	10157-103A4	45.89	8.55
parietal lobe, adult, pool1	10034-101E7	20.97	4.23
parietal lobe, fetal, donor1	10072-101I9	963.05	116.38
parietal lobe, newborn, donor10223	10356-105E5	140.20	17.20
parotid gland, adult	10199-103F1	33.30	9.87
penis, adult	10200-103F2	54.79	13.96
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	298.06	99.10
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	88.87	9.32
pineal gland - adult, donor10196	10179-103C8	27.09	6.45
pineal gland, adult, donor10252	10160-103A7	93.57	14.21
pineal gland, adult, donor10258	10377-105G8	28.85	5.64
pituitary gland - adult, donor10196	10180-103C9	15.18	2.02
pituitary gland, adult, donor10252	10162-103A9	30.23	4.17
pituitary gland, adult, donor10258	10378-105G9	15.32	3.40
placenta, adult, pool1	10021-101D3	52.57	7.85
plasma cell leukemia cell line:ARH-77	10840-111E3	739.21	55.35
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	165.60	21.17
pons, adult, pool1	10033-101E6	12.91	1.55
postcentral gyrus, adult, pool1	10032-101E5	49.78	9.68
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	666.47	60.59
promyelocytes/myelocytes PMC, donor3	12140-128E7	927.12	93.89
prostate cancer cell line:DU145	10490-107B4	85.07	12.53
prostate cancer cell line:PC-3	10439-106E7	312.36	33.03
prostate, adult, pool1	10022-101D4	40.45	6.08
putamen, adult, donor10196	10176-103C5	38.71	4.72
putamen, adult, donor10252	10152-102I8	33.33	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	75.40	10.93
putamen, adult, donor10258, tech_rep2	10372-105G3	23.68	3.87
putamen, newborn, donor10223	10365-105F5	176.17	19.49
rectal cancer cell line:TT1TKB	10469-106I1	139.36	20.37
rectum, fetal, donor1	10067-101I4	663.50	77.90
renal cell carcinoma cell line:OS-RC-2	10411-106B6	136.74	17.17
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	45.98	7.04
retina, adult, pool1	10030-101E3	44.93	7.85
retinoblastoma cell line:Y79	10475-106I7	1203.92	141.85
rhabdomyosarcoma cell line:KYM-1	10787-110H4	110.78	10.70
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	1625.06	180.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	26.52	7.58
salivary acinar cells, donor1	11771-123I7	54.87	5.34
salivary acinar cells, donor2	11772-123I8	52.18	4.82
salivary acinar cells, donor3	11773-123I9	17.88	0.66
salivary gland, adult, pool1	10093-102C3	28.03	9.15
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	112.47	17.62
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	139.89	21.04
seminal vesicle, adult	10201-103F3	55.02	7.41
serous adenocarcinoma cell line:JHOS-2	10639-108I9	83.08	11.66
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	50.58	11.58
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	304.07	30.11
serous cystadenocarcinoma cell line:HTOA	10693-109F9	68.10	11.01
signet ring carcinoma cell line:Kato III	10436-106E4	390.72	29.84
signet ring carcinoma cell line:NUGC-4	10483-107A6	175.86	33.16
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	1.42
skeletal muscle, adult, pool1	10023-101D5	3.96	0.96
skeletal muscle, fetal, donor1	10066-101I3	361.81	52.26
skin, adult, donor1	10074-102A2	115.35	0.00
skin, fetal, donor1	10065-101I2	306.78	45.45
small cell cervical cancer cell line:HCSC-1	10800-110I8	365.54	22.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	40.35	8.51
small cell lung carcinoma cell line:DMS 144	10841-111E4	401.88	40.28
small cell lung carcinoma cell line:LK-2	10541-107H1	16.48	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	655.14	71.90
small cell lung carcinoma cell line:WA-hT	10562-108A4	152.98	19.61
small intestine, adult, pool1	10024-101D6	79.79	13.02
small intestine, fetal, donor1	10064-101I1	234.64	36.12
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	81.55	15.90
smooth muscle, adult, pool1	10048-101G3	40.06	3.62
somatostatinoma cell line:QGP-1	10781-110G7	26.00	2.14
spinal cord - adult, donor10196	10181-103D1	85.80	20.65
spinal cord, adult, donor10252	10159-103A6	34.30	3.55
spinal cord, adult, donor10258	10369-105F9	11.07	3.46
spinal cord, fetal, donor1	10056-101H2	218.32	28.05
spinal cord, newborn, donor10223	10359-105E8	47.30	7.81
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	61.98	5.38
spleen, adult, pool1	10025-101D7	97.58	12.67
spleen, fetal, pool1	10044-101F8	195.46	26.30
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	428.64	47.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	54.30	6.84
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	47.53	6.99
squamous cell carcinoma cell line:T3M-5	10616-108G4	96.17	20.72
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	382.09	55.92
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	0.00	0.00
stomach, fetal, donor1	10062-101H8	130.29	22.43
submaxillary gland, adult	10202-103F4	55.26	9.11
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	19.32	3.53
substantia nigra, adult, donor10258	10371-105G2	10.35	3.62
substantia nigra, newborn, donor10223	10358-105E7	75.60	9.89
synovial sarcoma cell line:HS-SY-II	10441-106E9	543.59	75.20
temporal lobe, adult, pool1	10031-101E4	50.18	10.26
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	739.33	113.96
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	521.29	149.88
tenocyte, donor1	11763-123H8	74.01	9.43
tenocyte, donor2	11765-123I1	13.73	2.29
tenocyte, donor3	11768-123I4	33.36	4.08
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	379.01	27.53
teratocarcinoma cell line:NCR-G1	10798-110I6	319.24	36.07
teratocarcinoma cell line:PA-1	10807-111A6	349.94	26.35
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	289.82	39.10
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	245.81	73.37
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	92.70	21.27
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	495.07	101.29
testis, adult, pool1	10026-101D8	114.46	15.14
testis, adult, pool2	10096-102C6	134.42	32.03
thalamus - adult, donor10196	10168-103B6	32.02	12.14
thalamus, adult, donor10252	10154-103A1	20.79	2.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	10.78	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	23.55	4.78
thalamus, newborn, donor10223	10366-105F6	82.85	9.78
throat, adult	10209-103G2	99.37	19.22
throat, fetal, donor1	10061-101H7	293.74	48.14
thymic carcinoma cell line:Ty-82	10803-111A2	689.20	75.92
thymus, adult, pool1	10027-101D9	2216.66	251.42
thymus, fetal, pool1	10043-101F7	791.34	98.50
thyroid carcinoma cell line:KHM-5M	10776-110G2	449.27	61.03
thyroid carcinoma cell line:TCO-1	10783-110G9	199.76	16.20
thyroid, adult, pool1	10028-101E1	32.10	3.08
thyroid, fetal, donor1	10060-101H6	70.13	8.70
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	6.16
tongue, adult	10203-103F5	104.19	17.21
tongue, fetal, donor1	10059-101H5	115.08	13.40
tonsil, adult, pool1	10047-101G2	224.79	24.24
trachea, adult, pool1	10029-101E2	30.92	3.35
trachea, fetal, donor1	10058-101H4	237.36	27.70
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	131.08	20.19
transitional-cell carcinoma cell line:5637	10418-106C4	396.35	47.11
transitional-cell carcinoma cell line:JMSU1	10492-107B6	314.94	43.09
tridermal teratoma cell line:HGRT	10694-109G1	83.71	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	21.50	2.03
umbilical cord, fetal, donor1	10057-101H3	54.25	12.52
uterus, adult, pool1	10100-102D1	51.19	18.09
uterus, fetal, donor1	10055-101H1	445.89	74.74
vagina, adult	10204-103F6	7.75	0.65
vein, adult	10191-103E2	177.77	37.92
xeroderma pigentosum b cell line:XPL 17	10563-108A5	227.52	26.97